Oral health and risk of pneumonia in asthmatic patients with inhaled treatment

Medicina Clínica (English Edition) - Tập 150 - Trang 455-459 - 2018
Francesc Rodríguez1, Analía Duran2, Zulema Muñoz2, Elisabet Palomera3, Mateu Serra-Prat3,4, Ramón Boixeda5, Vanesa Vicente6, Jordi Almirall1,7
1Unidad de Cuidados Intensivos, Hospital de Mataró, Consorcio Sanitario del Maresme, Mataró, Barcelona, Spain
2Servicio de Urgencias, Hospital de Mataró, Consorcio Sanitario del Maresme, Mataró, Barcelona, Spain
3Departamento de Epidemiología, Investigación y Desarrollo, Hospital de Mataró. Consorcio sanitario del Maresme, Mataró, Barcelona, Spain
4Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain
5Servicio de Medicina Interna, Hospital de Mataró, Consorcio Sanitario del Maresme, Mataró, Barcelona, Spain
6Hospital de Día Onco-hematología y Neumología, Hospital de Mataró, Consorcio Sanitario del Maresme, Mataró, Barcelona, Spain
7Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Barcelona, Spain

Tài liệu tham khảo

Myers, 2011, Asthma: 2015 and beyond, Respir Care, 56, 1389, 10.4187/respcare.01334 Martínez-Moragón, 2009, Coste económico del paciente asmático en España (estudio AsmaCost), Arch Bronconeumol, 45, 481, 10.1016/j.arbres.2009.04.006 Kerstjens, 2012, Tiotropium in asthma poorly controlled with standard combination therapy, N Engl J Med, 367, 1198, 10.1056/NEJMoa1208606 Fernández, 2012, Depósito pulmonar de partículas inhaladas, Arch Bronconeumol, 48, 240, 10.1016/j.arbres.2012.02.003 Prieto-Prieto, 2004, Bases microbiológicas en las infecciones bucales y sensibilidad en los antibióticos, Med Oral Patol Oral Cir Bucal, 9, 11 Almirall, 2010, Inhaled drugs as risk factors for community acquired pneumonia, Eur Respir J, 36, 1080, 10.1183/09031936.00022909 Almirall, 2008, New evidence of risk factors for community-acquired pneumonia: a population-based study, Eur Respir J, 31, 1274, 10.1183/09031936.00095807 Rodríguez, 2014, Poor oral health as risk factor for community-acquired pneumonia, J Pulm Respir Med, 4, 5, 10.4172/2161-105X.1000203 Arlette, 1999, Detección de necesidades de atención bucodental en ancianos mediante la autopercepción de la salud oral, Rev Mult Gerontol, 9, 216 Misrachi, 2005, Utilidad de las mediciones de la calidad de vida relacionada con la salud, Rev Dent Chile, 96, 28 Herdman, 2001, El EuroQol-5D: una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en atención primaria, Aten Primaria, 28, 425, 10.1016/S0212-6567(01)70406-4 Yi Mohammadi, 2015, Effectiveness of professional oral health care intervention on the oral health of residents with dementia in residential aged care facilities: a systematic review protocol, JBI Database Syst Rev Implement Rep, 13, 110, 10.11124/jbisrir-2015-2330 Terpenning, 2005, Geriatric oral health and pneumonia risk, Clin Infect Dis, 40, 1807, 10.1086/430603 Almirall, 2015, Risk factors for community-acquired pneumonia in adults: recommendations for its prevention, Community Acquir Infect, 2, 23, 10.4103/2225-6482.159217 Wilson, 2012, Asthma outcomes: quality of life, J Allergy Clin Immunol, 129, 88, 10.1016/j.jaci.2011.12.988 Zewe, 2003, Living with asthma, Nurs Clin North Am, 38, 749, 10.1016/S0029-6465(03)00098-7 Cabré, 2006, Factores pronóstico de la neumonía adquirida en la comunidad en ancianos, Med Clin (Barc), 127, 201, 10.1157/13091011 Fried, 2001, Frailty in older adults: evidence for a phenotype, J Gerontol, 56, 146, 10.1093/gerona/56.3.M146 Cabre, 2010, Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia, Age Ageing, 39, 39, 10.1093/ageing/afp100 Chatterjee, 2016, Anticholinergic medication use and risk of pneumonia in elderly adults: a nested case–control study, J Am Geriatr Soc, 64, 394, 10.1111/jgs.13932 Barnes, 2012, Severe asthma: advances in current management and future therapy, J Allergy Clin Immunol, 129, 48, 10.1016/j.jaci.2011.11.006 McKeever, 2013, Inhaled corticosteroids and the risk of pneumonia in people with asthma, Chest, 144, 1788, 10.1378/chest.13-0871 To, 2004, Influence of inhaled corticosteroides on community-acquired pneumonia in patients with bronchial asthma, Intern Med, 43, 674, 10.2169/internalmedicine.43.674 Bansal, 2015, Inhaled corticosteroids and incident pneumonia in patients with asthma: systematic review and meta-analysis, Acta Med Acad, 44, 135, 10.5644/ama2006-124.141 O’Byrne, 2011, Risks of pneumonia in patients with asthma taking inhaled corticosteroids, Am J Respir Crit Care Med, 183, 589, 10.1164/rccm.201005-0694OC Chauhan, 2013, Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults, Cochrane Database Syst Rev Grupo de Trabajo de la SEPAR, 2013, Cámaras de inhalación y espaciadores, Arch Bronconeumol, 49, 2 Plaza, 2016, Terapia inhalada en el asma, Med Clin (Barc), 146, 316, 10.1016/j.medcli.2015.09.021 Pérez de Llano, 2010, Relación entre presencia de comorbilidad y control del asma, Arch Bronconeumol, 46, 508, 10.1016/j.arbres.2010.05.008 Martínez-Rivera, 2011, Perfil psicológico de los pacientes con asma bronquial y disnea funcional: comparación con población no asmática e impacto sobre la enfermedad, Arch Bronconeumol, 47, 73, 10.1016/j.arbres.2010.10.003